Radiation rectal injury subtypes and outcomes study
Part of Digestive system clinical trials.
This study looks at different types of radiation rectal injury to understand how they affect recovery. It may help you if you have been diagnosed with this condition and are not currently undergoing cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You have been diagnosed with radiation rectal injury
- You are not currently getting cancer therapy
- Your cancer has not come back or spread
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a dietary supplement to help heal damage inside the rectum caused by pelvic radiation therapy. If you have mild to moderate rectal bleeding but no signs of cancer recurrence, you may be able to join.
This trial tests whether a Bergmann enema can help prevent radiation-related rectal injury during short-course radiotherapy for rectal cancer. It may be an option for people who are about to start pelvic radiation.
This trial studies a combination of SBRT (a precise kind of radiation) and an immunotherapy drug (PD-1 antibody) for people whose rectal cancer has come back in the pelvis and cannot be removed by surgery. The goal is to see if this treatment can shrink the tumor or stop it from growing.
This trial tests targeted radiation (SBRT) for people whose rectal cancer has come back in the pelvis and cannot be surgically removed. The goal is to see if this focused radiation can control the tumor with fewer side effects.
This registry study collects information from people who are planning to receive radiation therapy. The goal is to better understand treatment outcomes and help improve radiation care over time.
This study compares two types of pre-surgery radiation—protons versus standard photons—in people with high-risk rectal cancer. The goal is to shrink and control the tumor while safely getting you ready for surgery, and to see which approach works better.
Hear when a new Radiotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.